{"id":7232,"date":"2019-05-07T08:34:55","date_gmt":"2019-05-07T12:34:55","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=7232"},"modified":"2019-05-07T08:34:55","modified_gmt":"2019-05-07T12:34:55","slug":"aptinyx-aptxnas-and-aslan-pharmaceuticals-aslnnas-trading-at-less-than-cash-value","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2019\/05\/07\/aptinyx-aptxnas-and-aslan-pharmaceuticals-aslnnas-trading-at-less-than-cash-value\/","title":{"rendered":"Aptinyx (APTX:NAS) and ASLAN Pharmaceuticals (ASLN:NAS) Trading at Less than Cash Value"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Trading at Less than Cash Value<\/h4>\n

Today we are looking at companies trading at less than cash value<\/strong> meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.<\/p>\n

What this Means…<\/h5>\n

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P\/E greater than 0 and are worth exploring in more detail.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nClose Price<\/th>\nShares Outstanding<\/th>\nP\/E<\/th>\nP\/B<\/th>\nCash per Share<\/th>\nNet Cash per Share<\/th>\n<\/tr>\n
SOHU<\/td>\nSohu.com Ltd<\/td>\n20.000000<\/td>\n39228538<\/td>\nNone<\/td>\n1.4657<\/td>\n21.38<\/td>\n12.30<\/td>\n<\/tr>\n
PRTA<\/td>\nProthena Corp PLC<\/td>\n10.560000<\/td>\n39863711<\/td>\nNone<\/td>\n1.3033<\/td>\n10.73<\/td>\n9.43<\/td>\n<\/tr>\n
FTR<\/td>\nFrontier Communications Corp<\/td>\n2.060000<\/td>\n105318646<\/td>\nNone<\/td>\n0.1455<\/td>\n3.36<\/td>\n-159.69<\/td>\n<\/tr>\n
TA<\/td>\nTravelCenters of America LLC<\/td>\n4.020000<\/td>\n40397551<\/td>\nNone<\/td>\n0.3618<\/td>\n7.78<\/td>\n-9.95<\/td>\n<\/tr>\n
NHTC<\/td>\nNatural Health Trends Corp<\/td>\n11.510000<\/td>\n11398695<\/td>\n4.2007<\/td>\n1.4600<\/td>\n11.64<\/td>\n0.13<\/td>\n<\/tr>\n
APTX<\/td>\nAptinyx Inc<\/td>\n3.780000<\/td>\n33562211<\/td>\nNone<\/td>\n0.8497<\/td>\n4.49<\/td>\nNone<\/td>\n<\/tr>\n
ASLN<\/td>\nASLAN Pharmaceuticals Ltd<\/td>\n3.650000<\/td>\n32049788<\/td>\nNone<\/td>\n3.8207<\/td>\n27.57<\/td>\n14.24<\/td>\n<\/tr>\n
SORL<\/td>\nSORL Auto Parts Inc<\/td>\n3.710000<\/td>\n19304921<\/td>\n5.6212<\/td>\n0.4054<\/td>\n3.81<\/td>\n-9.32<\/td>\n<\/tr>\n
SCPH<\/td>\nscPharmaceuticals Inc<\/td>\n3.600000<\/td>\n18580430<\/td>\nNone<\/td>\n0.8495<\/td>\n4.82<\/td>\n4.30<\/td>\n<\/tr>\n
NLNK<\/td>\nNewLink Genetics Corp<\/td>\n1.790000<\/td>\n37276102<\/td>\nNone<\/td>\n0.5795<\/td>\n3.24<\/td>\n3.24<\/td>\n<\/tr>\n
CDTX<\/td>\nCidara Therapeutics Inc<\/td>\n2.440000<\/td>\n26641851<\/td>\nNone<\/td>\n1.0992<\/td>\n2.80<\/td>\n2.43<\/td>\n<\/tr>\n
AQXP<\/td>\nAquinox Pharmaceuticals Inc<\/td>\n2.690000<\/td>\n23537368<\/td>\nNone<\/td>\n0.8713<\/td>\n3.27<\/td>\n3.27<\/td>\n<\/tr>\n
MLNT<\/td>\nMelinta Therapeutics Inc<\/td>\n4.620000<\/td>\n11779897<\/td>\nNone<\/td>\n0.2863<\/td>\n6.94<\/td>\n-2.43<\/td>\n<\/tr>\n
TST<\/td>\nTheStreet Inc<\/td>\n6.890000<\/td>\n5336639<\/td>\n3.2090<\/td>\n0.6617<\/td>\n6.94<\/td>\n8.63<\/td>\n<\/tr>\n
PDSB<\/td>\nPDS Biotechnology Corp<\/td>\n5.870000<\/td>\n5348174<\/td>\nNone<\/td>\n1.0521<\/td>\n6.48<\/td>\n10.11<\/td>\n<\/tr>\n
APWC<\/td>\nAsia Pacific Wire & Cable Corp Ltd<\/td>\n2.240000<\/td>\n13819669<\/td>\n10.6667<\/td>\n0.2063<\/td>\n4.40<\/td>\n2.60<\/td>\n<\/tr>\n
ADXS<\/td>\nAdvaxis Inc<\/td>\n3.570000<\/td>\n8006984<\/td>\nNone<\/td>\n0.7623<\/td>\n4.09<\/td>\n14.08<\/td>\n<\/tr>\n
GIGM<\/td>\nGigaMedia Ltd<\/td>\n2.480000<\/td>\n11052235<\/td>\n28.0000<\/td>\n0.4756<\/td>\n5.25<\/td>\n5.77<\/td>\n<\/tr>\n
GEVO<\/td>\nGevo Inc<\/td>\n2.122500<\/td>\n11885678<\/td>\nNone<\/td>\n0.2841<\/td>\n2.84<\/td>\n1.78<\/td>\n<\/tr>\n
TNXP<\/td>\nTonix Pharmaceuticals Holding Corp<\/td>\n2.100000<\/td>\n6089728<\/td>\nNone<\/td>\n0.5404<\/td>\n4.11<\/td>\n7.16<\/td>\n<\/tr>\n
CLRB<\/td>\nCellectar Biosciences Inc<\/td>\n2.420000<\/td>\n5102709<\/td>\nNone<\/td>\n1.1503<\/td>\n2.60<\/td>\n2.60<\/td>\n<\/tr>\n
MDGS<\/td>\nMedigus Ltd<\/td>\n2.789200<\/td>\n3796602<\/td>\nNone<\/td>\n1.3107<\/td>\n2.80<\/td>\nNone<\/td>\n<\/tr>\n
KBSF<\/td>\nKBS Fashion Group Ltd<\/td>\n3.847500<\/td>\n2228497<\/td>\nNone<\/td>\n0.1579<\/td>\n9.07<\/td>\n8.58<\/td>\n<\/tr>\n
BLIN<\/td>\nBridgeline Digital Inc<\/td>\n5.310000<\/td>\n324825<\/td>\nNone<\/td>\n0.4403<\/td>\n6.47<\/td>\n-1.29<\/td>\n<\/tr>\n
JMU<\/td>\nJMU Ltd<\/td>\n1.640000<\/td>\n819615<\/td>\nNone<\/td>\n0.0661<\/td>\n12.09<\/td>\n3.21<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

APTX:NAS Aptinyx<\/h6>\n

https:\/\/www.aptinyx.com<\/a>
\nAptinyx has 63 employees and is headquartered in United States.
\nAptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.<\/p>\n

ASLN:NAS ASLAN Pharmaceuticals<\/h6>\n

http:\/\/www.aslanpharma.com<\/a>
\nASLAN Pharmaceuticals has 56 employees and is headquartered in Singapore.
\nASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

30 Days for Free!<\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n